Cardiff Oncology CRDF
NASDAQ CRDF
$0.88 -0.03 (-3.15%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cardiff Oncology (CRDF) Amortizatization of Intangibles (2014 - 2025)

Cardiff Oncology (CRDF) posted Amortizatization of Intangibles of $158000.0 for Q4 2025, down 37.3% sequentially from $252000.0 in Q3 2025, and little changed YoY from $158000.0 in Q4 2024.

Cardiff Oncology (CRDF) Amortizatization of Intangibles (2014 - 2025) Analysis & Trends

Cardiff Oncology has reported Amortizatization of Intangibles for 9 years, with the latest figure at $158000.0 in Q4 2025.

  • Quarterly Amortizatization of Intangibles changed 0.0% year-over-year to $158000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $848000.0 (up 41.81% YoY) and the FY2025 annual result came in at $848000.0, up 41.81% from the prior year.
  • Amortizatization of Intangibles eased to $158000.0 in Q4 2025 per CRDF's latest filing, from $252000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $311000.0 in Q3 2023 and troughed at -$494000.0 in Q2 2021.
  • A 5-year average of $6400.0 and a median of $146500.0 in 2024 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles plunged 69.61% in 2022, then jumped 412.5% in 2023.
  • Over 5 years, Amortizatization of Intangibles stood at -$447000.0 in 2021, then surged by 108.95% to $40000.0 in 2022, then surged by 412.5% to $205000.0 in 2023, then decreased by 22.93% to $158000.0 in 2024, then changed by 0.0% to $158000.0 in 2025.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $158000.0, $252000.0, and $301000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cardiff Oncology 60.21 Mn 60.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 158,000.00
Dec 31, 2025 158,000.00
Sep 30, 2025 252,000.00
Sep 30, 2025 252,000.00
Jun 30, 2025 301,000.00
Jun 30, 2025 301,000.00
Mar 31, 2025 137,000.00
Mar 31, 2025 137,000.00
Dec 31, 2024 158,000.00
Dec 31, 2024 158,000.00
Sep 30, 2024 157,000.00
Sep 30, 2024 157,000.00
Jun 30, 2024 127,000.00
Jun 30, 2024 127,000.00
Mar 31, 2024 156,000.00
Mar 31, 2024 156,000.00
Dec 31, 2023 205,000.00
Dec 31, 2023 205,000.00
Sep 30, 2023 311,000.00
Sep 30, 2023 311,000.00